Homare Eda

Medicine · Health Sciences

14h-index1.3kcitations43works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(35), Bone health and treatments(9), Protein Degradation and Inhibitors(9), Peptidase Inhibition and Analysis(8), Histone Deacetylase Inhibitors Research(7)

Publications43 total

Data from Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor, AZD8055, in Multiple Myeloma
2023Open Access
Supplementary Figure 1 from Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor, AZD8055, in Multiple Myeloma
2023Open Access
Data from Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor, AZD8055, in Multiple Myeloma
2023Open Access
Supplementary Figure 1 from Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor, AZD8055, in Multiple Myeloma
2023Open Access
<scp>TRACP</scp> ‐ <scp>5b</scp> / <scp>BAP</scp> Score After 3 Months of Treatment With Combined <scp>SERM</scp> / <scp>E2</scp> Therapy Can Predict Changes in Lumbar Spine Bone Mineral Density After 1 Year of Treatment in Early Postmenopausal Osteopenia
JBMR Plus·2022· 2 citedOpen Access
Author response for "&lt;scp&gt;TRACP&lt;/scp&gt; ‐5b/ &lt;scp&gt;BAP&lt;/scp&gt; score after 3 months of treatment with combined &lt;scp&gt;SERM&lt;/scp&gt; / &lt;scp&gt;E2&lt;/scp&gt; therapy can predict changes in lumbar spine bone mineral density after 1 year of treatment in early postmenopausal osteopenia"
2022
Concomitant Suppression of IKZF1, IRF4 and MYC Contribute to the Anti-Tumor Activity of the BET Inhibitor, Cpi-0610, in Disease Models of Multiple Myeloma
Blood·2016· 2 cited
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma
Leukemia·2016· 76 cited
Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancy
Journal of Clinical Investigation·2016· 14 citedOpen Access
Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease
Journal of Bone and Mineral Research·2016· 98 citedOpen Access
Bone Disease in Multiple Myeloma
Cancer treatment and research·2016· 28 cited
Effect of the BET Inhibitor, Cpi-0610, Alone and in Combination with Lenalidomide in Multiple Myeloma
Blood·2015· 15 cited
The Biologic Relevance of PIM Kinases in the Context of Multiple Myeloma and Their Potential As Therapeutic Targets in Combination Drug Therapy
Blood·2015
Novel In Vivo Model of Multiple Myeloma Bone Disease Using ß-Tricalcium Phosphate Artificial Bone Grafts
Blood·2015
Ricolinostat (<scp>ACY</scp>‐1215) induced inhibition of aggresome formation accelerates carfilzomib‐induced multiple myeloma cell death
British Journal of Haematology·2015· 99 cited
Effect of the Pan-PIM Kinase Inhibitor, AZD1208, Alone and in Combination with Bortezomib in Multiple Myeloma
Blood·2014
Role of Decorin in Multiple Myeloma (MM) Bone Marrow Microenvironment
Journal of Bone and Mineral Research·2014· 18 citedOpen Access
Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor, AZD8055, in Multiple Myeloma
Molecular Cancer Therapeutics·2014· 25 citedOpen Access
A novel Bruton’s tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity
Leukemia·2014· 42 cited
A Novel Bruton′s Tyrosine Kinase Inhibitor CC-292 In Combination With The Proteasome Inhibitor Carfilzomib Iimpacts Multiple Myeloma Bone Microenviroment With Resultant Anti-Myeloma Activity
Blood·2013· 1 cited
page 1 of 3Next →

Frequent Co-authors

Noopur Raje(36), Diana Cirstea(30), Neeharika Nemani(19), Andrew J. Yee(18), Teru Hideshima(15), Kenneth C. Anderson(15), Loredana Santo(14), Anuj Mahindra(14), Yuko Mishima(13), Loredana Santo(12), Loredana Santo(10), Sonia Vallet(8), Yiguo Hu(8), Hiroto Ohguchi(8), Janani Ramachandran(7), Francesca Cottini(7), Güllü Görgün(7), Rikio Suzuki(7), Sylvie M. Guichard(7), Miriam Canavese(6)